JPH0422587B2 - - Google Patents
Info
- Publication number
- JPH0422587B2 JPH0422587B2 JP57224743A JP22474382A JPH0422587B2 JP H0422587 B2 JPH0422587 B2 JP H0422587B2 JP 57224743 A JP57224743 A JP 57224743A JP 22474382 A JP22474382 A JP 22474382A JP H0422587 B2 JPH0422587 B2 JP H0422587B2
- Authority
- JP
- Japan
- Prior art keywords
- blood
- plasma
- circulating
- amount
- circulation system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000004369 blood Anatomy 0.000 claims description 232
- 239000008280 blood Substances 0.000 claims description 232
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 85
- 238000005534 hematocrit Methods 0.000 claims description 62
- 238000000746 purification Methods 0.000 claims description 62
- 230000017531 blood circulation Effects 0.000 claims description 51
- 230000003204 osmotic effect Effects 0.000 claims description 47
- 230000008859 change Effects 0.000 claims description 27
- 239000012530 fluid Substances 0.000 claims description 20
- 239000012528 membrane Substances 0.000 claims description 17
- 238000000502 dialysis Methods 0.000 claims description 15
- 230000001276 controlling effect Effects 0.000 claims description 14
- 238000005259 measurement Methods 0.000 claims description 13
- 239000003792 electrolyte Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 11
- 239000002699 waste material Substances 0.000 claims description 11
- 230000001105 regulatory effect Effects 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 3
- 230000004087 circulation Effects 0.000 claims description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 53
- 239000011780 sodium chloride Substances 0.000 description 32
- 238000002347 injection Methods 0.000 description 13
- 239000007924 injection Substances 0.000 description 13
- 210000001124 body fluid Anatomy 0.000 description 9
- 239000010839 body fluid Substances 0.000 description 9
- 238000012937 correction Methods 0.000 description 9
- 230000007423 decrease Effects 0.000 description 9
- 238000001631 haemodialysis Methods 0.000 description 9
- 230000000322 hemodialysis Effects 0.000 description 9
- 238000010586 diagram Methods 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 238000005303 weighing Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 210000003722 extracellular fluid Anatomy 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010034567 Peripheral circulatory failure Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57224743A JPS59115051A (ja) | 1982-12-21 | 1982-12-21 | 血液浄化装置 |
| DE8383102324T DE3374660D1 (en) | 1982-03-10 | 1983-03-09 | Blood purification apparatus |
| US06/473,574 US4469593A (en) | 1982-03-10 | 1983-03-09 | Blood purification apparatus |
| EP83102324A EP0089003B1 (fr) | 1982-03-10 | 1983-03-09 | Appareil de purification du sang |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57224743A JPS59115051A (ja) | 1982-12-21 | 1982-12-21 | 血液浄化装置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59115051A JPS59115051A (ja) | 1984-07-03 |
| JPH0422587B2 true JPH0422587B2 (fr) | 1992-04-17 |
Family
ID=16818537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57224743A Granted JPS59115051A (ja) | 1982-03-10 | 1982-12-21 | 血液浄化装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59115051A (fr) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004505708A (ja) * | 2000-08-14 | 2004-02-26 | リーナル リサーチ インスティテュート，リミティド ライアビリティー カンパニー | 透析患者の断片的生体インピーダンスを測定するデバイスおよび方法 |
| JP2014131739A (ja) * | 2007-07-05 | 2014-07-17 | Baxter Internatl Inc | 導電性接触を用いる透析流体測定システム |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0683723B2 (ja) * | 1987-05-28 | 1994-10-26 | 株式会社医療工学研究所 | 透析効率制御装置 |
| JP4374660B2 (ja) * | 1999-06-23 | 2009-12-02 | 株式会社ジェイ・エム・エス | 血液透析装置、血液透析装置を使用した血液処理方法および該血液透析装置を制御する記録媒体 |
| US7303667B2 (en) * | 2001-07-03 | 2007-12-04 | Jms Co., Ltd. | Blood dialysis apparatus having convenient controlling unit |
| CA2455410C (fr) * | 2001-07-27 | 2011-09-13 | Jms Co., Ltd. | Dialyseur sanguin |
| EP1421958A4 (fr) | 2001-08-01 | 2008-10-08 | Jms Co Ltd | Appareil de purification du sang permettant d'augmenter l'efficacite de la purification |
| US7022098B2 (en) * | 2002-04-10 | 2006-04-04 | Baxter International Inc. | Access disconnection systems and methods |
| US7138088B2 (en) * | 2002-04-10 | 2006-11-21 | Baxter International Inc. | Access disconnection system and methods |
| US7356366B2 (en) | 2004-08-02 | 2008-04-08 | Cardiac Pacemakers, Inc. | Device for monitoring fluid status |
| DE102014108444A1 (de) * | 2014-06-16 | 2015-12-17 | Fresenius Medical Care Deutschland Gmbh | Verfahren und Vorrichtungen zum Bereitstellen einer Lösung für die Blutbehandlung |
| JP6739144B2 (ja) * | 2014-11-12 | 2020-08-12 | 日機装株式会社 | 帯電防止具 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5737457A (en) * | 1980-08-19 | 1982-03-01 | Kazuo Ootsu | Vertical descent type shelter device |
| JPS5784063A (en) * | 1980-11-14 | 1982-05-26 | Nissho Kk | Controller for concentration of solute |
-
1982
- 1982-12-21 JP JP57224743A patent/JPS59115051A/ja active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5737457A (en) * | 1980-08-19 | 1982-03-01 | Kazuo Ootsu | Vertical descent type shelter device |
| JPS5784063A (en) * | 1980-11-14 | 1982-05-26 | Nissho Kk | Controller for concentration of solute |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004505708A (ja) * | 2000-08-14 | 2004-02-26 | リーナル リサーチ インスティテュート，リミティド ライアビリティー カンパニー | 透析患者の断片的生体インピーダンスを測定するデバイスおよび方法 |
| JP2014131739A (ja) * | 2007-07-05 | 2014-07-17 | Baxter Internatl Inc | 導電性接触を用いる透析流体測定システム |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59115051A (ja) | 1984-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4469593A (en) | Blood purification apparatus | |
| JP4159250B2 (ja) | 透析効率を計算するための方法および装置 | |
| US8070707B2 (en) | Controller for ultrafiltration blood circuit which prevent hypotension by monitoring osmotic pressure in blood | |
| US8764987B2 (en) | Device and method for determining and controlling the concentration of at least one solute in a fluid circuit | |
| JP4509387B2 (ja) | 体外血液処理中に血液成分の分布量を算定するための方法およびこの方法を実施するための装置 | |
| KR100970414B1 (ko) | 혈액 치료 장치를 위한 제어 장치 및 제어 방법 | |
| JP4254913B2 (ja) | 血液処理装置用安全装置及び血液処理装置の安全性を高めるための方法 | |
| JP4059926B2 (ja) | 透析中症候を防ぐための血液治療用システム | |
| CN107666919B (zh) | 用于体外血液处理的设备 | |
| JPH0422587B2 (fr) | ||
| CA2336923C (fr) | Procede pour determiner la dialysance et dispositif permettant de le mettre en oeuvre | |
| EP3865160B1 (fr) | Appareil pour traitement sanguin extracorporel | |
| EP3374001B1 (fr) | Appareil de traitement sanguin extracorporel - ii | |
| JPH0422586B2 (fr) | ||
| AU2002313902B2 (en) | Blood purification apparatus for elevating purification efficiency | |
| CN113260391B (zh) | 用于体外血液处理的装置 | |
| EP4098291A1 (fr) | Appareil de traitement extracorporel du sang | |
| Ronco et al. | Adequacy of renal replacement therapy | |
| Ota et al. | Clinical Evaluation of a Pre‐Set Ultrafiltration Rate Controller Available for Single Pass and Hemodiafiltration Systems | |
| JPH0423558Y2 (fr) | ||
| JP2003102832A (ja) | 血液透析装置 |